MedPath

Comparing the Effect of Benzoyl Proxide 5% and IPL andto Proxide 5%-alone in acne

Phase 2
Completed
Conditions
Acne vulgaris.
Acne vulgaris
Registration Number
IRCT2016051727947N1
Lead Sponsor
Isfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
58
Inclusion Criteria

being afflicted with mild-to-moderate acne; patients who prefer to receive therapies faster than commonly used time-consuming treatments; having no acne scar; no pregnancy of breast feeding; consent to participate; receiving no antibiotic during past wo weeks or systemic steroid and retinoid during past 6 months; photosensitivity; no tendency to develop hyperthrophic scar;
Exclusion criteria: sensitivity to benzoyl peroxide; no regular visits; using co-treatments.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Acne Severity Index. Timepoint: Befor and 1, 2, 3 months after initiation and 1 month after the last visit. Method of measurement: Calculating corresponding formula based on the number of injuries.
Secondary Outcome Measures
NameTimeMethod
Acne Global Severity Scale. Timepoint: Before, 1,2,3 month after treatment and 1 month after final treatment. Method of measurement: Calculating corresponding formula based on the number of injuries.
© Copyright 2025. All Rights Reserved by MedPath